Sector updates in November
Investment firms
- Therese Liechtenstein joined 4BIO as Investment Director
- Jupiter Bioventures launches with $70M fund dedicated to biotech startups developing cancer therapeutics or advancing adjacent programs based on cancer biology
Media
- Elizabeth Cairns to join Endpoints as Senior Biopharma Reporter
- Olivia Freitt has been appointed Editor at European Pharmaceutical Manufacturer
- Carrie Haslam has been appointed Editor at Drug Target Review
- Joe Quiruga has been appointed Editor at HealthInvestor
- Pandora Dewan has been appointed Trending News Editor at Live Science (US)
- Amy Feldman has been appointed Senior Editor for Healthcare at Forbes (US)
- Kelsey Hayes to join New Scientist as Chief Sub-Editor from January 2025